Breaking News

Over a quarter ago
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
SPHS

Sophiris Bio

$3.07

0.5 (19.46%)

09:45
08/29/18
08/29
09:45
08/29/18
09:45
Recommendations
Sophiris Bio analyst commentary at H.C. Wainwright »

Sophiris Bio price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SPHS

Sophiris Bio

$2.57

-0.06 (-2.28%)

09:16
08/29/18
08/29
09:16
08/29/18
09:16
Recommendations
Sophiris Bio analyst commentary at Piper Jaffray »

Piper expects shares of…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SPHS

Sophiris Bio

$2.57

-0.06 (-2.28%)

08:06
08/29/18
08/29
08:06
08/29/18
08:06
Hot Stocks
Sophiris Bio provides update on patient death in prostate cancer trial »

Sophiris Bio announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SPHS

Sophiris Bio

$2.74

0.13 (4.98%)

18:37
08/14/18
08/14
18:37
08/14/18
18:37
Recommendations
Sophiris Bio analyst commentary at Piper Jaffray »

Sophiris Bio topsalycin…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SPHS

Sophiris Bio

$2.74

0.13 (4.98%)

16:07
08/14/18
08/14
16:07
08/14/18
16:07
Earnings
Sophiris Bio reports Q2 EPS (20c), consensus (15c) »

Reports Q2 revenue $0,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SPHS

Sophiris Bio

$2.34

-1.41 (-37.60%)

06:53
06/26/18
06/26
06:53
06/26/18
06:53
Recommendations
Sophiris Bio analyst commentary at Piper Jaffray »

Sophiris Bio 'worth…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SPHS

Sophiris Bio

$2.24

-1.51 (-40.27%)

16:07
06/25/18
06/25
16:07
06/25/18
16:07
Recommendations
Sophiris Bio analyst commentary at Piper Jaffray »

Piper says Sophiris Bio…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SPHS

Sophiris Bio

$2.22

-1.53 (-40.80%)

14:01
06/25/18
06/25
14:01
06/25/18
14:01
Recommendations
Sophiris Bio analyst commentary at Maxim »

Sophiris Bio's…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SPHS

Sophiris Bio

$2.22

-1.53 (-40.80%)

13:07
06/25/18
06/25
13:07
06/25/18
13:07
Recommendations
Sophiris Bio analyst commentary at H.C. Wainwright »

Sophiris Bio price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

XRM

Xerium Technologies

$6.61

(0.00%)

, MACK

Merrimack

$9.16

(0.00%)

09:20
06/25/18
06/25
09:20
06/25/18
09:20
Hot Stocks
On The Fly: Pre-market Movers »

HIGHER: Xerium…

XRM

Xerium Technologies

$6.61

(0.00%)

MACK

Merrimack

$9.16

(0.00%)

GTN

Gray Television

$12.80

(0.00%)

FSLR

First Solar

$52.64

(0.00%)

SPHS

Sophiris Bio

$3.75

(0.00%)

KR

Kroger

$29.74

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jun

  • 28

    Jun

  • 06

    Sep

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.